Revenue
EPS
EBIT
Revenue is based on 0 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: JPY
Unlock Free Earnings Estimates
Immuno-Biological Laboratories: Notice regarding revisions to full-year earnings forecasts
Feb 18 01:30 ET
Immuno-Biological Laboratories: Summary of Financial Results for the 3rd Quarter Ending March 31, 2025 [Japanese GAAP] (Consolidated)
Feb 10 01:30 ET
Immuno-Biological Laboratories: Financial results presentation materials for the second quarter (interim period) for the fiscal year ending March 31, 2025 (43rd period)
Nov 28, 2024 01:30 ET
Immuno-Biological Laboratories: Confirmation letter
Nov 13, 2024 19:04 ET
Read more